Interstitial lung disease (ILD) progression in patients with systemic sclerosis–associated ILD (SSc-ILD) did not predict subsequent progression at the next annual follow-up, with only 20% ...

Enrolled first PH-ILD patient in the open-label ASCENT study of YUTREPIA Confirmed with FDA that a single pivotal efficacy trial with L606 will support PAH and PH-ILD indications MORRISVILLE ...

Militant groups within the country including most predominantly the Popular Mobilization Forces (PMF) continue to represent a major headache for the US government. The PMF holds major political ...

Several powerful Iraqi Shiite militias, backed by Iran, joined PMF ranks shortly after – some of which had been fighting alongside former president Bashar Al Assad's forces in Syria’s civil war.

BAGHDAD, March 8 (Reuters) - Iraq's Popular Mobilization Forces (PMF) said that state-owned group Muhandis had signed a wide-ranging memorandum of understanding with Chinese construction giant ...

Nerandomilast improved FVC in the FIBRONEER-ILD trial, meeting its primary end point in patients with progressive pulmonary fibrosis. Safety and tolerability results were consistent with previous ...